Full text 2026

From ALL to Myeloid and NK Malignancies: Operationalizing “ASNS-Low” for L-Asparaginase Repurposing and Combination Therapy

Unknown

Full text

Loading PDF… Expand reader Download

Abstract

No abstract available.

Keywords

Asparagine synthetase Proteomics L-asparaginase Biomarker Acute myeloid leukemia Combination therapy Nk/t-cell Lymphoma Companion Diagnostic Intracellular Flow Cytometry Asns-Low